Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/25/2870072/0/en/GENFIT-Publication-of-the-2024-Extra-Financial-Performance-Report-fiscal-year-2023.html
https://www.globenewswire.com/news-release/2024/04/15/2863164/0/en/GENFIT-Annual-Combined-General-Meeting-of-May-22-2024-Availability-of-Preparatory-Documents.html
https://www.globenewswire.com/news-release/2024/04/05/2858689/0/en/GENFIT-Announces-Publication-of-the-2023-Universal-Registration-Document-and-the-2023-Annual-Report-on-Form-20-F.html
https://www.globenewswire.com/news-release/2024/04/04/2858206/0/en/GENFIT-Reports-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/01/15/2809404/0/en/GENFIT-Announces-2024-Financial-Calendar.html
https://www.globenewswire.com//news-release/2023/12/08/2792998/0/en/GENFIT-Updates-2024-Outlook-Following-Acceptance-of-Elafibranor-Filings-in-Primary-Biliary-Cholangitis-PBC.html
https://www.globenewswire.com/news-release/2023/12/06/2791971/0/en/GENFIT-Announces-Publication-in-the-Journal-of-Hepatology-on-the-Accurate-Performance-of-NIS2-as-a-Screening-Tool-for-the-Enrollment-of-Patients-in-MASH-Clinical-Trials.html
https://www.globenewswire.com//news-release/2023/11/16/2782252/0/en/GENFIT-Highlights-ACLF-Development-Strategy-at-ACLF-Day-during-AASLD-The-Liver-Meeting-2023.html
https://www.globenewswire.com//news-release/2023/11/13/2779520/0/en/Results-from-Ipsen-s-ELATIVE-pivotal-Phase-III-trial-of-elafibranor-in-PBC-presented-as-late-breaking-data-at-AASLD-congress-and-published-in-New-England-Journal-of-Medicine.html
https://www.globenewswire.com//news-release/2023/11/02/2772912/0/en/GENFIT-to-Present-Update-on-Scientific-and-Corporate-Progress-at-The-Liver-Meeting-2023.html